What is the share price of Fischer Medical Ventures Ltd (FISCHER) today?
The share price of FISCHER as on 18th June 2025 is ₹848. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fischer Medical Ventures Ltd (FISCHER) share?
The past returns of Fischer Medical Ventures Ltd (FISCHER) share are- Past 1 week: -0.69%
- Past 1 month: -5.33%
- Past 3 months: 7.32%
- Past 6 months: 22.78%
- Past 1 year: 21.62%
- Past 3 years: 949.57%
- Past 5 years: 1795.54%
What are the peers or stocks similar to Fischer Medical Ventures Ltd (FISCHER)?
The peers or stocks similar to Fischer Medical Ventures Ltd (FISCHER) include:What is the dividend yield % of Fischer Medical Ventures Ltd (FISCHER) share?
The current dividend yield of Fischer Medical Ventures Ltd (FISCHER) is 0.00.What is the market cap of Fischer Medical Ventures Ltd (FISCHER) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fischer Medical Ventures Ltd (FISCHER) is ₹5667.05 Cr as of 18th June 2025.What is the 52 week high and low of Fischer Medical Ventures Ltd (FISCHER) share?
The 52-week high of Fischer Medical Ventures Ltd (FISCHER) is ₹919 and the 52-week low is ₹573.60.What is the PE and PB ratio of Fischer Medical Ventures Ltd (FISCHER) stock?
The P/E (price-to-earnings) ratio of Fischer Medical Ventures Ltd (FISCHER) is 3829.09. The P/B (price-to-book) ratio is 69.87.Which sector does Fischer Medical Ventures Ltd (FISCHER) belong to?
Fischer Medical Ventures Ltd (FISCHER) belongs to the Utilities sector & Power Trading & Consultancy sub-sector.How to buy Fischer Medical Ventures Ltd (FISCHER) shares?
You can directly buy Fischer Medical Ventures Ltd (FISCHER) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fischer Medical Ventures Ltd
FISCHER Share Price
How to use scorecard? Learn more
FISCHER Performance & Key Metrics
FISCHER Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
4,166.95 | 69.87 | 0.00% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
20.68 | 3.04 | 1.46% |
FISCHER Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
FISCHER Company Profile
Fischer Medical Ventures Limited is primarily involved in trading laboratory chemicals and machinery. The company focuses on providing essential supplies for laboratory operations.
FISCHER Forecast
FISCHER Forecasts
FISCHER
FISCHER
Income
Balance Sheet
Cash Flow
FISCHER Income Statement
FISCHER Income Statement
Financial Year | FY 2023 | FY 2024 | FY 2025 | TTM | ||||
---|---|---|---|---|---|---|---|---|
Total Revenue | 0.18 | 21.48 | 112.19 | 112.19 | ||||
Raw Materials | 0.00 | 0.08 | 107.87 | 107.86 | ||||
Power & Fuel Cost | 0.00 | 0.19 | ||||||
Employee Cost | 0.05 | 0.38 | ||||||
Selling & Administrative Expenses | 0.11 | 1.84 | ||||||
Operating & Other expenses | 0.00 | 16.64 | ||||||
EBITDA | 0.02 | 2.35 | 4.32 | 4.33 | ||||
Depreciation/Amortization | 0.00 | 0.18 | 1.63 | 1.64 | ||||
PBIT | 0.02 | 2.17 | 2.69 | 2.69 | ||||
Interest & Other Items | 0.02 | 0.07 | 0.47 | 0.48 | ||||
PBT | 0.00 | 2.10 | 2.22 | 2.21 | ||||
Taxes & Other Items | 0.04 | 0.27 | 0.74 | 0.85 | ||||
Net Income | -0.04 | 1.83 | 1.48 | 1.36 | ||||
EPS | -2.33 | 0.68 | 0.22 | 0.25 | ||||
DPS | 0.00 | 0.00 | 0.05 | 0.00 | ||||
Payout ratio | 0.00 | 0.00 | 0.23 | 0.00 |
FISCHER Company Updates
FISCHER Stock Peers
FISCHER Past Performance & Peer Comparison
FISCHER Past Performance & Peer Comparison
UtilitiesPower Trading & Consultancy
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Fischer Medical Ventures Ltd | 3,829.09 | 69.87 | 0.00% |
Indian Energy Exchange Ltd | 39.39 | 17.39 | 1.58% |
Rattanindia Enterprises Ltd | 97.76 | 9.77 | — |
PTC India Ltd | 5.85 | 0.87 | 6.58% |
FISCHER Stock Price Comparison
Compare FISCHER with any stock or ETFFISCHER Holdings
FISCHER Shareholdings
FISCHER Promoter Holdings Trend
FISCHER Promoter Holdings Trend
FISCHER Institutional Holdings Trend
FISCHER Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
FISCHER Shareholding Pattern
FISCHER Shareholding Pattern
FISCHER Shareholding History
FISCHER Shareholding History
smallcases containing FISCHER stock
smallcases containing FISCHER stock
Looks like this stock is not in any smallcase yet.
FISCHER Events
FISCHER Events
FISCHER Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
FISCHER Dividend Trend
No dividend trend available
FISCHER Dividends
FISCHER Dividends
FISCHER Stock News & Opinions
FISCHER Stock News & Opinions
Fischer Medical Ventures announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 0.05 per equity Share (i.e. 0.5%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Fischer Medical Ventures declined 42.08% to Rs 1.50 crore in the quarter ended March 2025 as against Rs 2.59 crore during the previous quarter ended March 2024. Sales rose 136.51% to Rs 49.17 crore in the quarter ended March 2025 as against Rs 20.79 crore during the previous quarter ended March 2024. For the full year,net profit declined 20.11% to Rs 1.47 crore in the year ended March 2025 as against Rs 1.84 crore during the previous year ended March 2024. Sales rose 427.65% to Rs 110.70 crore in the year ended March 2025 as against Rs 20.98 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales49.1720.79 137 110.7020.98 428 OPM %4.8812.12 -2.568.87 - PBDT2.322.93 -21 3.862.29 69 PBT1.812.75 -34 2.222.11 5 NP1.502.59 -42 1.471.84 -20 Powered by Capital Market - Live
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 26 March 2025.Powered by Capital Market - Live
Net profit of Fischer Medical Ventures reported to Rs 0.20 crore in the quarter ended December 2024 as against net loss of Rs 0.13 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
Time Medical International Ventures (India) has become the first Magnetic Resonance Imaging (MRI) manufacturer in India to receive the official license to manufacture for sale or distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the CDSCO. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: EMMA - 1.5T MRI Scanner, PICA - 0.35T MRI Scanner, MICA - 1.5T MRI Scanner and QUIN - 1.5T MRI Scanner. The EMMA, MICA, and QUIN MRI systems are 1.5T MRI scanners, offering exceptional imaging resolution and precision for a wide range of clinical applications, while the PICA model is a 0.35T MRI scanner, tailored for specific diagnostic needs. These models are available for distribution across India, helping to address the growing demand for reliable and advanced medical imaging solutions. We are thrilled to be the first Make in India company to receive the CDSCO license for the manufacturing and distribution of MRI systems. This achievement demonstrates the strength and potential of India's medical device manufacturing sector. With our EMMA, PICA, MICA, and QUIN MRI systems, we are committed to providing hospitals and diagnostic centers with cutting-edge, affordable diagnostic imaging solutions,' said the Management Team of Fischer Medical Ventures. Fischer Medical Ventures has changed the nature of Business from Manufacturing of Chemicals to Trading and Manufacturing of Medical equipment including MRI machines consequent to share subscription agreement. The company reported consolidated net profit of Rs 0.29 crore in Q2 FY25 as against net loss of Rs 0.12 crore in Q1 FY25. Net sales surged 291.9% YoY to Rs 39.66 crore in the September 2024 quarter. Powered by Capital Market - Live
Fischer Medical Ventures announced that its wholly owned subsidiary, Time Medical International Ventures (India) has become the first indigenous MRI manufacturer in India to receive the official License to Manufacture for Sale or Distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the Central Drugs Standard Control Organization (CDSCO). This achievement marks a significant milestone in the Make in India initiative, reinforcing the company''s commitment to developing high-quality, locally manufactured medical devices that meet international standards. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: 'h EMMA - 1.5T MRI Scanner 'h PICA - 0.35T MRI Scanner 'h MICA - 1.5T MRI Scanner 'h QUIN - 1.5T MRI ScannerPowered by Capital Market - Live
Fischer Medical Ventures announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 January 2025.Powered by Capital Market - Live
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 3 January 2025.Powered by Capital Market - Live
Pledged promoter holdings is insignificant